Showing results (111-120 of 187) with videos related to

Sort By:
Pageof 19
Leukemia & Lymphoma|November 6, 2012
Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myelomaNicole Wong Doo, Philip A Thompson, H Miles Prince, et al.
Calcified Tissue International|February 20, 2024
Bone Density and Trabecular Bone Score Decline Rapidly in the First Year After Bone Marrow Transplantation with a Marked Increase in 10-Year Fracture RiskJoanna Y Gong, Cherie Chiang, John D Wark, et al.
Leukemia & Lymphoma|April 21, 2026
Impact of peri-transplant consolidative radiotherapy in patients with relapsed or refractory classical Hodgkin lymphomaBelinda A Campbell, Adrian Minson, Rachel J Brown, et al.
BMJ Open|November 1, 2020
Study protocol of a pilot study evaluating feasibility and acceptability of a psychosexual intervention for couples postallogeneic haematopoietic stem cell transplantationBrindha Pillay, Maria Ftanou, David Ritchie, et al.
Haematologica|July 18, 2009
Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series reportDavid Ritchie, Richard L Piekarz, Piers Blombery, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 25, 2014
Myelosuppressive therapies significantly increase pro-inflammatory cytokines and directly cause bone lossJulie M Quach, Maria Askmyr, Tanja Jovic, et al.
Open Forum Infectious Diseases|October 9, 2025
Incidence and Clinical Outcomes of Multiple Viral Infections After Allogeneic Hematopoietic Cell TransplantationKar Yee Yong, Shio Yen Tio, Beatrice Z Sim, et al.
BMC Psychiatry|January 10, 2023
Inequalities in children's mental health care: analysis of routinely collected data on prescribing and referrals to secondary careWilliam P Ball, Corri Black, Sharon Gordon, et al.
Haematologica|July 21, 2007
Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcomeLinda Mileshkin, Dirk Honemann, Peter Gambell, et al.
Optics Express|October 14, 2010
Injection-locking of terahertz quantum cascade lasers up to 35GHz using RF amplitude modulationPierre Gellie, Stefano Barbieri, Jean-François Lampin, et al.
Pageof 19